A 6-week Open Label Cross-over Study With 2 Different Daily Doses of Minirin® Oral Lyophilisate in Children and Adolescents With Primary Nocturnal Enuresis (PNE)

PHASE4CompletedINTERVENTIONAL

Enrollment

221

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

August 31, 2005

Study Completion Date

September 30, 2005

Conditions

Primary Nocturnal Enuresis

Interventions

DRUG

MINIRIN Oral Lyophilisate

DRUG

Minirin tablet

Trial Locations (1)

Service de Chirurrgie Viscerale Pediatrique Hospital Necker-Enfants Malades, Paris